BREAKING: New cancer drug holds hope for man's best friend - Could this be the cure we've been waiting for?

A groundbreaking multi-center clinical trial funded by the Bernese Mountain Dog Club of America is set to evaluate the potential of a cancer drug to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, a typically fatal canine cancer. Dr. Vilma Yuzbasiyan-Gurkan, the study's Principal Investigator, shares her excitement about the targeted approach using the drug trametinib, showing promising results in tests against canine sarcoma cell lines and mouse models.